PERSPECTA

News from every angle

Back to headlines

Warnings Against Off-Label Use of Diabetes Drug Mounjaro for Diet

Japanese medical societies and pharmaceutical companies are issuing warnings against the use of the Type 2 diabetes drug Mounjaro for weight loss purposes, citing potential health risks despite its promotion on social media and by beauty clinics.

PostShare